# AI Steps In to Combat Fatty Liver Disease Epidemic Early detection through AI could save lives in this silent global health crisis affecting over 1 billion people. - **Source:** [Science Latest](https://brifing.si/source/ebc20f22-8d1a-4ae4-ba4c-efcd0853ba19) - **Published:** 2026-08-13 - **Original article:** - **On Brifing:** https://brifing.si/s/ea6e6527-36c6-4b43-8498-608d8fa1cac4 ## The silent global epidemic Over 1 billion people worldwide have liver fat levels exceeding healthy thresholds (5%). This condition leads to inflammation and potentially fatal fibrosis. High-risk groups include those with obesity and type 2 diabetes. Since symptoms often appear late, 75% of cases are diagnosed only when life-threatening complications arise, highlighting the need for early detection methods. ## AI's diagnostic breakthrough Prof. Jeffrey Lazarus from CUNY School of Public Health advocates using AI to screen electronic health records for at-risk patients. Algorithms analyzing existing data can outperform traditional methods like Fib-4 index by 4x. AI systems capable of scanning routine blood tests and X-rays for liver abnormalities are proving particularly valuable for early warning systems. ## Revolutionizing routine imaging Researchers at Osaka Metropolitan University developed an AI model that analyzes routine chest X-rays, achieving 82% accuracy in detecting fatty liver disease from incidental liver views. This approach transforms millions of existing scans into diagnostic opportunities without requiring additional specialized imaging. ## Next-generation blood analysis Danish startup Evido's LiverPRO algorithm evaluates 9 biomarkers plus age to assess fibrosis risk. Tested on 470,000+ middle-aged individuals, it outperformed Fib-4 with fewer false positives. Now being commercialized with Roche, this innovation represents a significant leap in accessible liver health screening. ## Expanding treatment horizons Early-stage interventions like alcohol reduction, weight loss, and increased coffee consumption can reverse fibrosis. For advanced cases, new therapies like semaglutide (GLP-1 medication) and resmetirom show promise. AI is also being used to identify optimal candidates for these treatments, personalizing care pathways. ## Healthcare system integration challenges Widespread adoption of AI solutions requires seamless integration into clinical workflows. Prof. Jonathan Dranoff from Yale emphasizes the need for background automation: 'We need systems that either run automatically or require just one click.' Overcoming physician workload barriers remains crucial for implementation. ## Transforming preventive medicine The liver's regenerative capacity makes early intervention particularly effective. AI-powered screening could shift medicine from late-stage treatment to prevention. Incorporating AI into monitoring protocols for high-risk groups may deliver long-term cost savings for healthcare systems while dramatically improving outcomes. ## Impact on global health policies As fatty liver disease affects 30% of adults worldwide, AI solutions are gaining priority in national health strategies. Their potential as low-cost screening tools could be transformative in developing countries. Experts predict AI will optimize referral pathways to hepatology and endocrinology clinics, creating more efficient healthcare ecosystems. ## Sources covering this story - https://www.wired.com/story/fatty-liver-disease-ai-detection-cancer/ — --- _Summary written by Brifing from the original reporting. Copyright in the original article belongs to its publisher; read the full piece at the link above._